| Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective … A Pastore, V Jurinovic, R Kridel, E Hoster, AM Staiger, M Szczepanowski, ... The lancet oncology 16 (9), 1111-1122, 2015 | 632 | 2015 |
| Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies DW Scott, A Mottok, D Ennishi, GW Wright, P Farinha, S Ben-Neriah, ... Journal of clinical oncology 33 (26), 2848, 2015 | 439 | 2015 |
| Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma R Kridel, B Meissner, S Rogic, M Boyle, A Telenius, B Woolcock, ... Blood, The Journal of the American Society of Hematology 119 (9), 1963-1971, 2012 | 406 | 2012 |
| Pathogenesis of follicular lymphoma R Kridel, LH Sehn, RD Gascoyne The Journal of clinical investigation 122 (10), 3424-3431, 2012 | 397 | 2012 |
| Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma R Rahal, M Frick, R Romero, JM Korn, R Kridel, F Chun Chan, B Meissner, ... Nature medicine 20 (1), 87-92, 2014 | 393 | 2014 |
| Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma D Ennishi, A Jiang, M Boyle, B Collinge, BM Grande, S Ben-Neriah, ... Journal of Clinical Oncology 37 (3), 190, 2019 | 322 | 2019 |
| Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma DDW Twa, FC Chan, S Ben-Neriah, BW Woolcock, A Mottok, KL Tan, ... Blood, The Journal of the American Society of Hematology 123 (13), 2062-2065, 2014 | 320 | 2014 |
| Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition D Ennishi, K Takata, W Béguelin, G Duns, A Mottok, P Farinha, ... Cancer discovery 9 (4), 546-563, 2019 | 246 | 2019 |
| Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma J Gunawardana, FC Chan, A Telenius, B Woolcock, R Kridel, KL Tan, ... Nature genetics 46 (4), 329-335, 2014 | 238 | 2014 |
| Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy V Jurinovic, R Kridel, AM Staiger, M Szczepanowski, H Horn, MH Dreyling, ... Blood, The Journal of the American Society of Hematology 128 (8), 1112-1120, 2016 | 236 | 2016 |
| Histological transformation and progression in follicular lymphoma: a clonal evolution study R Kridel, FC Chan, A Mottok, M Boyle, P Farinha, K Tan, B Meissner, ... PLoS medicine 13 (12), e1002197, 2016 | 230 | 2016 |
| Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL KJ Savage, GW Slack, A Mottok, LH Sehn, D Villa, R Kansara, R Kridel, ... Blood, The Journal of the American Society of Hematology 127 (18), 2182-2188, 2016 | 195 | 2016 |
| Gene expression–based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma DW Scott, FC Chan, F Hong, S Rogic, KL Tan, B Meissner, S Ben-Neriah, ... Journal of Clinical Oncology 31 (6), 692, 2013 | 194 | 2013 |
| The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma B Meissner, R Kridel, RS Lim, S Rogic, K Tse, DW Scott, R Moore, ... Blood, The Journal of the American Society of Hematology 121 (16), 3161-3164, 2013 | 149 | 2013 |
| The prognostic impact of CD163-positive macrophages in follicular lymphoma: a study from the BC cancer agency and the lymphoma study association R Kridel, L Xerri, B Gelas-Dore, K Tan, P Feugier, A Vawda, D Canioni, ... Clinical Cancer Research 21 (15), 3428-3435, 2015 | 133 | 2015 |
| Prevention of CNS relapse in diffuse large B-cell lymphoma R Kridel, PY Dietrich The lancet oncology 12 (13), 1258-1266, 2011 | 131 | 2011 |
| Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact D Ennishi, A Mottok, S Ben-Neriah, HP Shulha, P Farinha, FC Chan, ... Blood, The Journal of the American Society of Hematology 129 (20), 2760-2770, 2017 | 129 | 2017 |
| Cell of origin of transformed follicular lymphoma R Kridel, A Mottok, P Farinha, S Ben-Neriah, D Ennishi, Y Zheng, ... Blood, The Journal of the American Society of Hematology 126 (18), 2118-2127, 2015 | 128 | 2015 |
| An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids … M Probst-Kepper, V Stroobant, R Kridel, B Gaugler, C Landry, F Brasseur, ... The Journal of experimental medicine 193 (10), 1189-1198, 2001 | 122 | 2001 |
| Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration JWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ... Journal of Clinical Oncology 37 (34), 3300, 2019 | 112 | 2019 |
Randy D GascoyneProfessor of Pathology, University of British ColumbiaVerified email at bccancer.bc.ca
